Portal-724 MEMS for Medication Adherence Patients Taking HCV Medications

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 9, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

January 25, 2018

Conditions
Adherence
Interventions
DEVICE

Portal-724 MEMs Cap

Trial Locations (1)

07102

Saint Michael's Medical Center, Newark

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Saint Michael's Medical Center

OTHER

NCT02858050 - Portal-724 MEMS for Medication Adherence Patients Taking HCV Medications | Biotech Hunter | Biotech Hunter